The estimated Net Worth of Gotham Makker is at least $17.5 Milione dollars as of 21 March 2024. Gotham Makker owns over 274,000 units of Rocket Pharmaceuticals Inc stock worth over $6,963,305 and over the last 7 years he sold RCKT stock worth over $10,199,970. In addition, he makes $325,912 as Independent Director at Rocket Pharmaceuticals Inc.
Gotham has made over 4 trades of the Rocket Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 274,000 units of RCKT stock worth $7,789,820 on 21 March 2024.
The largest trade he's ever made was selling 274,000 units of Rocket Pharmaceuticals Inc stock on 21 March 2024 worth over $7,789,820. On average, Gotham trades about 28,673 units every 84 days since 2018. As of 21 March 2024 he still owns at least 365,912 units of Rocket Pharmaceuticals Inc stock.
You can see the complete history of Gotham Makker stock trades at the bottom of the page.
Dr. Gotham Makker M.D. serves as Independent Director of the Company. Dr. Makker has over 17 years of healthcare industry experience. Dr. Makker currently serves as head of Strategic Investments for RTW Investments, LP (“RTW”), a position he has held since 2019. From 2005 to 2019, he served as Chief Executive Officer of Simran Investment Group, LLC, a closely held equity investment fund. Prior to Simran, Dr. Makker was a healthcare portfolio manager and principal at Citadel Investment Group LLC, a position he held from 2002 to 2005. Prior to joining Citadel, Dr. Makker served as an analyst at Oracle Partners LP covering biotechnology and medical device sectors from 2000 to 2001. From 1999 to 2000, Dr. Makker was a senior analyst on the life sciences investment banking team at Hambrecht & Quist. Dr. Makker has previously served on the board of directors of Health Sciences Acquisitions Corporation. Dr. Makker received an M.D. from the University of Nebraska Medical School, and he completed the Sarnoff cardiovascular research fellowship at Columbia University, College of Physicians & Surgeons and at Harvard Medical School, Brigham & Women’s Hospital.
As the Independent Director of Rocket Pharmaceuticals Inc, the total compensation of Gotham Makker at Rocket Pharmaceuticals Inc is $325,912. There are 12 executives at Rocket Pharmaceuticals Inc getting paid more, with Gaurav Shah having the highest compensation of $3,883,650.
Gotham Makker is 45, he's been the Independent Director of Rocket Pharmaceuticals Inc since 2018. There are 10 older and 6 younger executives at Rocket Pharmaceuticals Inc. The oldest executive at Rocket Pharmaceuticals Inc is Pedro Granadillo, 73, who is the Independent Director.
Gotham's mailing address filed with the SEC is C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY, NJ, 08512.
Over the last 7 years, insiders at Rocket Pharmaceuticals Inc have traded over $45,364,690 worth of Rocket Pharmaceuticals Inc stock and bought 2,407,332 units worth $48,979,646 . The most active insiders traders include Investments, Lpwong Roderic..., Mikael Dolsten e Investments, Lpwong Roderic.... On average, Rocket Pharmaceuticals Inc executives and independent directors trade stock every 30 days with the average trade being worth of $1,269,815. The most recent stock trade was executed by John Militello on 16 August 2024, trading 1,064 units of RCKT stock currently worth $19,684.
rocket pharmaceuticals, ltd is a biotechnology company focused on seeking cures through molecular and gene therapy. we are developing first-in-class treatments for patients with rare and often devastating orphan diseases using a lentiviral-based gene therapy approach. we have developed rewarding partnerships with a number of leading international research institutions as well as with centers of manufacturing and cell processing expertise, while building an internal team to drive the research, development, clinical and regulatory programs. ultimately we aim to launch and globally commercialize innovative gene therapies in disease areas with high unmet need. for more information, please visit www.rocketpharma.com.
Rocket Pharmaceuticals Inc executives and other stock owners filed with the SEC include: